Kee Song Bio-Technology Holdings Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 651.25 million compared to TWD 563.45 million a year ago. Net income was TWD 47.86 million compared to TWD 24.63 million a year ago. Basic earnings per share from continuing operations was TWD 1.3 compared to TWD 0.66 a year ago. Diluted earnings per share from continuing operations was TWD 1.3 compared to TWD 0.57 a year ago.
For the six months, sales was TWD 1,257.61 million compared to TWD 1,140.79 million a year ago. Net income was TWD 66.69 million compared to TWD 41.05 million a year ago. Basic earnings per share from continuing operations was TWD 1.81 compared to TWD 1.11 a year ago. Diluted earnings per share from continuing operations was TWD 1.81 compared to TWD 0.97 a year ago.